Advertisement
Johnson & Johnson

Johnson & Johnson (JNJ) Stock Overview

Explore Johnson & Johnson’s financial performance, market position, analyst ratings, and future outlook.

JNJNYSE
HealthcareDrug Manufacturers - General
$240.21
$8.05(3.47%)
U.S. Market is Open · 10:32
Advertisement

Johnson & Johnson (JNJ)

Meyka AI Score

Z

Key Financials

Market Cap570.7B
P/E Ratio27.58
EPS (TTM)$8.64
ROE0.26%
Fundamental Analysis

AI Price Forecasts

1 Month$228.76
3 Months$273.44
1 Year Target$195.31

JNJ Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Johnson & Johnson (JNJ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 61.87, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $195.31.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 27.58 and a market capitalization of 570.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.09%
5-Day Change
4.37%
1-Month Change
7.09%
3-Month Change
-2.30%
6-Month Change
18.53%
Year-to-Date (YTD) Change
14.53%
1-Year Change
52.69%
3-Year Change
48.13%
5-Year Change
43.13%
All-Time (Max) Change
19327.46%

Contact Information

732 524 0400
One Johnson & Johnson Plaza, New Brunswick, NJ, 08933

Company Facts

138,100 Employees
IPO DateJan 2, 1943
CountryUS
Actively Trading

Frequently Asked Questions